EPLKX
Price
$21.88
Change
-$0.01 (-0.05%)
Updated
Sep 5 closing price
Net Assets
1.11B
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

EPLKX vs VVIAX

Header iconEPLKX vs VVIAX Comparison
Open Charts EPLKX vs VVIAXBanner chart's image
NYLI Epoch U.S. Equity Yield
Price$21.88
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets1.11B
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
EPLKX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EPLKX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPLKX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. EPLKX (1.11B). VVIAX pays higher dividends than EPLKX: VVIAX (2.10) vs EPLKX (1.12). EPLKX was incepted earlier than VVIAX: EPLKX (16 years) vs VVIAX (25 years). EPLKX (2.13) is less costly to investors than VVIAX (0.05). EPLKX is a more actively managed with annual turnover of: 13.00 vs. VVIAX (9.00). EPLKX has a lower initial minimum investment than VVIAX: EPLKX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. EPLKX (1.52). VVIAX return over 5 years is better than : 70.16 vs. EPLKX (52.70).
EPLKXVVIAXEPLKX / VVIAX
Total Expense Ratio2.080.054,160%
Annual Report Gross Expense Ratio2.130.054,260%
Fund Existence16 years25 years-
Gain YTD9.0277.850115%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B203B1%
Annual Yield % from dividends1.122.1053%
Returns for 1 year1.527.7420%
Returns for 3 years26.2236.6172%
Returns for 5 years52.7070.1675%
Returns for 10 years79.70131.6161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity